RIZATRIPTAN AS rizatriptan (as benzoate) 10 mg orally disintegrating tablets blisters

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

rizatriptan benzoate

Għamla farmaċewtika:

Tablet, orally disintegrating

Kompożizzjoni:

Excipient Ingredients: sodium stearylfumarate; hypromellose; crospovidone; silicon dioxide; mannitol; acesulfame potassium; ethylcellulose; colloidal anhydrous silica; Flavour

Rotta amministrattiva:

Sublingual

Unitajiet fil-pakkett:

3, 1, 2, 6

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

for acute treatment of migraine attacks with or without aura.

Sommarju tal-prodott:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C7' on one side and 'C' on the other side, having a characteristic flavour.; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2015-03-20